Pancreatic cancer study highlights body's natural molecules as potential treatment tools
Pancreatic cancer cells are remarkably good at doing one thing: growing. But new Texas A&M research suggests that two tiny molecules already present in the body may help slow them down.
A recent study from Texas A&M University has identified two microRNAs, miR-15a and miR-16, as potential treatment tools for pancreatic cancer. These tiny molecules are already present in the human body and help regulate protein synthesis, which is essential for cell growth. Researchers found that increasing levels of these microRNAs reduced protein synthesis and slowed the growth of pancreatic ductal adenocarcinoma (PDAC) cells.
Higher levels of miR-15a and miR-16 in tumors were also linked to better patient survival rates. The researchers believe that restoring these microRNAs specifically in cancer cells could provide a useful therapeutic approach for pancreatic cancer, although combining them with other treatments is likely necessary for effective patient care.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
